ArticleScientific reports2025
A robust method for autofluorescence-free immunofluorescence using high-speed fluorescence lifetime imaging microscopy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Predicting immune checkpoint inhibitors response via fluorescence lifetime imaging microscopy: a systematic review.Frontiers in immunology · 2025Pooled it
- A workflow to reduce red blood cell autofluorescence for imaging IL-4/IL-4R interactions in the inflamed lung.Biochemistry and biophysics reports · 2026Article
- Emerging trends of fluorescence lifetime imaging microscopy (FLIM): advances, challenges, and prospects.Biophysics reports · 2026Article
- Immunomodulatory Natural Products in Cancer Organoid-Immune Co-Cultures: Bridging the Research Gap for Precision Immunotherapy.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autofluorescence from endogenous biomolecules presents a significant challenge in immunofluorescence microscopy, often severely hindering the detection of specific fluorescence signals. While various techniques, including chemical- and quencher-based methods, photobleaching, and digital-based protocols like autofluorescence image subtraction, have been developed to suppress autofluorescence, each approach has inherent limitations that restrict their efficacy across different tissue types. Fluorescence lifetime imaging microscopy (FLIM) offers a powerful alternative by leveraging the distinct lifetime-spectrum profiles of fluorophores to differentiate specific immunofluorescence signals from autofluorescence. However, traditional FLIM methods are slow and have hampered its use for autofluorescence suppression in routine imaging applications. In this study, we demonstrate that GPU-accelerated high-speed FLIM can effectively separate autofluorescence from immunofluorescence signals in various tissue samples, achieving high throughput to meet the demands of biomedical and clinical workflows. Furthermore, our findings show that the FLIM-based autofluorescence suppression method enhances the correlation of immunofluorescence images with immunohistochemistry data, outperforming other methods like chemically-assisted photobleaching and hyperspectral imaging. These results highlight the potential of the high speed FLIM to improve the reliability of immunofluorescence microscopy significantly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.